Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Oncol. Mar 24, 2024; 15(3): 447-455
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.447

Full Size Figure Download Figure

Figure 5 Forest plots of survival rates at 6 and 12 months. A: 6 months; B: 12 months.

Citation: Sui WF, Li JY, Fu JH. Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis. World J Clin Oncol 2024; 15(3): 447-455
URL: https://www.wjgnet.com/2218-4333/full/v15/i3/447.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i3.447

Sui WF, Li JY, Fu JH. Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis. World J Clin Oncol 2024; 15(3): 447-455 [PMID: 38576592 DOI: 10.5306/wjco.v15.i3.447]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.